248 related articles for article (PubMed ID: 27009179)
1. Potential impact of spatially targeted adult tuberculosis vaccine in Gujarat, India.
Shrestha S; Chatterjee S; Rao KD; Dowdy DW
J R Soc Interface; 2016 Mar; 13(116):. PubMed ID: 27009179
[TBL] [Abstract][Full Text] [Related]
2. New tuberculosis vaccines in India: modelling the potential health and economic impacts of adolescent/adult vaccination with M72/AS01
Clark RA; Weerasuriya CK; Portnoy A; Mukandavire C; Quaife M; Bakker R; Scarponi D; Harris RC; Rade K; Mattoo SK; Tumu D; Menzies NA; White RG
BMC Med; 2023 Aug; 21(1):288. PubMed ID: 37542319
[TBL] [Abstract][Full Text] [Related]
3. Quantifying geographic heterogeneity in TB incidence and the potential impact of geographically targeted interventions in South and North City Corporations of Dhaka, Bangladesh: a model-based study.
Shrestha S; Reja M; Gomes I; Baik Y; Pennington J; Islam S; Jamil Faisel A; Cordon O; Roy T; Suarez PG; Hussain H; Dowdy DW
Epidemiol Infect; 2021 Apr; 149():e106. PubMed ID: 33866998
[TBL] [Abstract][Full Text] [Related]
4. Impact of Targeted Tuberculosis Vaccination Among a Mining Population in South Africa: A Model-Based Study.
Shrestha S; Chihota V; White RG; Grant AD; Churchyard GJ; Dowdy DW
Am J Epidemiol; 2017 Dec; 186(12):1362-1369. PubMed ID: 29253139
[TBL] [Abstract][Full Text] [Related]
5. Age-targeted tuberculosis vaccination in China and implications for vaccine development: a modelling study.
Harris RC; Sumner T; Knight GM; Evans T; Cardenas V; Chen C; White RG
Lancet Glob Health; 2019 Feb; 7(2):e209-e218. PubMed ID: 30630775
[TBL] [Abstract][Full Text] [Related]
6. The cost and cost-effectiveness of novel tuberculosis vaccines in low- and middle-income countries: A modeling study.
Portnoy A; Clark RA; Quaife M; Weerasuriya CK; Mukandavire C; Bakker R; Deol AK; Malhotra S; Gebreselassie N; Zignol M; Sim SY; Hutubessy RCW; Baena IG; Nishikiori N; Jit M; White RG; Menzies NA
PLoS Med; 2023 Jan; 20(1):e1004155. PubMed ID: 36693081
[TBL] [Abstract][Full Text] [Related]
7. Tuberculosis: vaccines in the pipeline.
Ly LH; McMurray DN
Expert Rev Vaccines; 2008 Jul; 7(5):635-50. PubMed ID: 18564018
[TBL] [Abstract][Full Text] [Related]
8. Systematic review of mathematical models exploring the epidemiological impact of future TB vaccines.
Harris RC; Sumner T; Knight GM; White RG
Hum Vaccin Immunother; 2016 Nov; 12(11):2813-2832. PubMed ID: 27448625
[TBL] [Abstract][Full Text] [Related]
9. Model-based impact evaluation of new tuberculosis vaccines in aging populations under different modeling scenarios: the case of China.
Tovar M; Sanz J; Moreno Y
Front Public Health; 2024; 12():1302688. PubMed ID: 38463158
[TBL] [Abstract][Full Text] [Related]
10. Is intranasal vaccination a feasible solution for tuberculosis?
Giri PK; Khuller GK
Expert Rev Vaccines; 2008 Nov; 7(9):1341-56. PubMed ID: 18980538
[TBL] [Abstract][Full Text] [Related]
11. The potential impact of vaccination on tuberculosis burden in India: A modelling analysis.
Arinaminpathy N; Rade K; Kumar R; Joshi RP; Rao R
Indian J Med Res; 2023; 157(2&3):119-126. PubMed ID: 37202930
[TBL] [Abstract][Full Text] [Related]
12. Potential impact of tuberculosis vaccines in China, South Africa, and India.
Harris RC; Sumner T; Knight GM; Zhang H; White RG
Sci Transl Med; 2020 Oct; 12(564):. PubMed ID: 33028708
[TBL] [Abstract][Full Text] [Related]
13. Tuberculosis vaccines and prevention of infection.
Hawn TR; Day TA; Scriba TJ; Hatherill M; Hanekom WA; Evans TG; Churchyard GJ; Kublin JG; Bekker LG; Self SG
Microbiol Mol Biol Rev; 2014 Dec; 78(4):650-71. PubMed ID: 25428938
[TBL] [Abstract][Full Text] [Related]
14. Modelling the global burden of drug-resistant tuberculosis avertable by a post-exposure vaccine.
Fu H; Lewnard JA; Frost I; Laxminarayan R; Arinaminpathy N
Nat Commun; 2021 Jan; 12(1):424. PubMed ID: 33462224
[TBL] [Abstract][Full Text] [Related]
15. The safety and immunogenicity of an adenovirus type 35-vectored TB vaccine in HIV-infected, BCG-vaccinated adults with CD4(+) T cell counts >350 cells/mm(3).
Churchyard GJ; Snowden MA; Hokey D; Dheenadhayalan V; McClain JB; Douoguih M; Pau MG; Sadoff J; Landry B
Vaccine; 2015 Apr; 33(15):1890-6. PubMed ID: 25698492
[TBL] [Abstract][Full Text] [Related]
16. Geospatial clustering and modelling provide policy guidance to distribute funding for active TB case finding in Ethiopia.
Shaweno D; Trauer JM; Doan TN; Denholm JT; McBryde ES
Epidemics; 2021 Sep; 36():100470. PubMed ID: 34052666
[TBL] [Abstract][Full Text] [Related]
17. [Novel vaccines against M. tuberculosis].
Okada M
Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
[TBL] [Abstract][Full Text] [Related]
18. Vaccination strategies to prevent tuberculosis in the new millennium: from BCG to new vaccine candidates.
Franco-Paredes C; Rouphael N; del Rio C; Santos-Preciado JI
Int J Infect Dis; 2006 Mar; 10(2):93-102. PubMed ID: 16377228
[TBL] [Abstract][Full Text] [Related]
19. Updating age-specific contact structures to match evolving demography in a dynamic mathematical model of tuberculosis vaccination.
Weerasuriya CK; Harris RC; McQuaid CF; Gomez GB; White RG
PLoS Comput Biol; 2022 Apr; 18(4):e1010002. PubMed ID: 35452459
[TBL] [Abstract][Full Text] [Related]
20. Affordability of Adult Tuberculosis Vaccination in India and China: A Dynamic Transmission Model-Based Analysis.
Weerasuriya CK; Harris RC; Quaife M; McQuaid CF; White RG; Gomez GB
Vaccines (Basel); 2021 Mar; 9(3):. PubMed ID: 33799544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
